101 related articles for article (PubMed ID: 7955113)
21. Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems.
Glatt H; Bartsch I; Christoph S; Coughtrie MW; Falany CN; Hagen M; Landsiedel R; Pabel U; Phillips DH; Seidel A; Yamazoe Y
Chem Biol Interact; 1998 Feb; 109(1-3):195-219. PubMed ID: 9566746
[TBL] [Abstract][Full Text] [Related]
22. Age- and sex-related differences in activation of the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene to an electrophilic sulfuric acid ester metabolite in rats. Possible involvement of hydroxysteroid sulfotransferase activity.
Surh YJ; Liem A; Miller EC; Miller JA
Biochem Pharmacol; 1991 Jan; 41(2):213-21. PubMed ID: 1824923
[TBL] [Abstract][Full Text] [Related]
23. Stable heterologous expression of hydroxysteroid sulphotransferase in Chinese hamster V79 cells and their use for toxicological investigations.
Czich A; Bartsch I; Dogra S; Hornhardt S; Glatt HR
Chem Biol Interact; 1994 Jun; 92(1-3):119-28. PubMed ID: 8033247
[TBL] [Abstract][Full Text] [Related]
24. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
[TBL] [Abstract][Full Text] [Related]
25. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
26. Salmonella strains and mammalian cells genetically engineered for expression of sulfotransferases.
Glatt H; Bartsch I; Czich A; Seidel A; Falany CN
Toxicol Lett; 1995 Dec; 82-83():829-34. PubMed ID: 8597149
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
[TBL] [Abstract][Full Text] [Related]
28. Methylene-bridged bay region chrysene and phenanthrene derivatives and their keto-analogs: mutagenicity in Salmonella typhimurium and tumor-initiating activity on mouse skin.
Rice JE; Makowski GS; Hosted TJ; Lavoie EJ
Cancer Lett; 1985 Jun; 27(2):199-206. PubMed ID: 3891075
[TBL] [Abstract][Full Text] [Related]
29. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
Utesch D; Glatt H; Oesch F
Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
[TBL] [Abstract][Full Text] [Related]
30. Identification of mutagenic metabolites of indeno[1,2,3-cd]pyrene formed in vitro with rat liver enzymes.
Rice JE; Coleman DT; Hosted TJ; LaVoie EJ; McCaustland DJ; Wiley JC
Cancer Res; 1985 Nov; 45(11 Pt 1):5421-5. PubMed ID: 4053016
[TBL] [Abstract][Full Text] [Related]
31. Bioactivation of 5-hydroxymethyl-2-furaldehyde to an electrophilic and mutagenic allylic sulfuric acid ester.
Lee YC; Shlyankevich M; Jeong HK; Douglas JS; Surh YJ
Biochem Biophys Res Commun; 1995 Apr; 209(3):996-1002. PubMed ID: 7733994
[TBL] [Abstract][Full Text] [Related]
32. 7-Sulfooxymethyl-12-methylbenz[a]anthracene is an electrophilic mutagen, but does not appear to play a role in carcinogenesis by 7,12-dimethylbenz[a]anthracene or 7-hydroxymethyl-12-methylbenz[a]anthracene.
Surh YJ; Liem A; Miller EC; Miller JA
Carcinogenesis; 1991 Feb; 12(2):339-47. PubMed ID: 1899811
[TBL] [Abstract][Full Text] [Related]
33. Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro.
Surh YJ; Liem A; Miller EC; Miller JA
Carcinogenesis; 1989 Aug; 10(8):1519-28. PubMed ID: 2752526
[TBL] [Abstract][Full Text] [Related]
34. Activation of propane 2-nitronate to a genotoxicant in V79-derived cell lines engineered for the expression of rat hepatic sulfotransferases.
Andrae U; Kreis P; Coughtrie MW; Pabel U; Meinl W; Bartsch I; Glatt H
Mutat Res; 1999 Feb; 439(2):191-7. PubMed ID: 10023057
[TBL] [Abstract][Full Text] [Related]
35. Bioactivation of 7-hydroxymethyl-12-methylbenz[a]anthracene by rat liver bile acid sulfotransferase I.
Falany CN; Wheeler J; Coward L; Keehan D; Falany JL; Barnes S
J Biochem Toxicol; 1992; 7(4):241-8. PubMed ID: 1293312
[TBL] [Abstract][Full Text] [Related]
36. Efficient oxidation of promutagenic hydroxymethylpyrenes by cDNA-expressed human alcohol dehydrogenase ADH2 and its inhibition by various agents.
Kollock R; Meinl W; Schneider H; Batke M; Frank H; Seidel A; Glatt H
Biochem Pharmacol; 2008 Jan; 75(2):527-37. PubMed ID: 17920042
[TBL] [Abstract][Full Text] [Related]
37. Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
Binder TP; Duffel MW
Mol Pharmacol; 1988 Apr; 33(4):477-9. PubMed ID: 3162759
[TBL] [Abstract][Full Text] [Related]
38. Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV.
Gilissen RA; Ringer DP; Stavenuiter HJ; Mulder GJ; Meerman JH
Carcinogenesis; 1992 Oct; 13(10):1699-703. PubMed ID: 1423828
[TBL] [Abstract][Full Text] [Related]
39. Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes.
Ogura K; Sohtome T; Sugiyama A; Okuda H; Hiratsuka A; Watabe T
Mol Pharmacol; 1990 Jun; 37(6):848-54. PubMed ID: 2113604
[TBL] [Abstract][Full Text] [Related]
40. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
